Latest Edition Released on Plaque Psoriasis Treatment Market

Plaque Psoriasis Treatment Market Latest Edition Published with Forecast to 2027
In Aug 2020, Novartis announced the European Commission (EC) has granted the approval for Cosentyx® (secukinumab) for the treatment of moderate-to-severe plaque psoriasis in children and adolescents aged 6 to <18 years. The recommended dose for children up to 50 kg is 75 mg (without a lower weight restriction), and 150 mg for children 50 kg and over (150 mg as a starting dose, which may be increased to 300 mg, if needed).

The article cited AMA's "Global Plaque Psoriasis Treatment Market Study" explored CAGR of %. According to the report, Increasing Approval of Pipeline Drugs and Supplemental Biologics is one of the primary growth factors for the market. Increasing Number of Pipeline Psoriasis Molecule and the Number of Biologics being Launched is also expected to contribute significantly to the Plaque Psoriasis Treatment market. Overall, Hospitals applications of Plaque Psoriasis Treatment, and the growing awareness of them, is what makes this segment of the industry important to its overall growth. The Drug Class, such as TNF-α Inhibitors, is boosting the Plaque Psoriasis Treatment market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.

AMA’s Analyst on the Global Plaque Psoriasis Treatment market identified that the demand is rising in many different parts of the world as "Increased Research and Development Funding ". Furthermore, some recent industry insights like "In Oct 2020, LEO Pharma Announces U.S. FDA Approval for Enstilar® (calcipotriene and betamethasone dipropionate) Foam U.S. Prescribing Information Update to Include Data in Long-term Use in Plaque Psoriasis Treatment" is constantly making the industry dynamic.

The report provides an in-depth analysis and forecast about the industry covering the following key features:
o Industry outlook including current and future market trends, drivers, restraints, and emerging technologies
o Analyses the Global Plaque Psoriasis Treatment market according to Type, Application, and regions
o Analyzes the top 10 players in terms of market reach, business strategy, and business focus
o Provides stakeholders’ insights and key drivers & trends of the market

**The market is valued based on weighted average selling price (WASP) and includes any applicable taxes on manufacturers. All currency conversions used in the creation of this report have been calculated using constant annual average 2018 currency rates.

Market Size Estimation
In market engineering method, both top-down and bottom-up approaches have been used, along with various data triangulation process, to predict and validate the market size of the Plaque Psoriasis Treatment market and other related sub-markets covered in the study.

o Key & emerging players in the market have been observed through secondary research.
o The industry’s supply chain and overall market size, in terms of value, have been derived through primary and secondary research processes.
o All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Have a look at detailed Table of Content for Plaque Psoriasis Treatment Market Study

Data Triangulation
The overall Plaque Psoriasis Treatment market size is calculated using market estimation process, the Plaque Psoriasis Treatment market was further split into various segments and sub-segments. To complete the overall market engineering and arriving at the exact statistics for all segments and sub-segments, the market breakdown and data triangulation procedures have been utilized, wherever applicable. The data have been triangulated by studying various influencing factors and trends identified from both demand and supply sides of various applications involved in the study. Along with this, the Global Plaque Psoriasis Treatment market size has been validated using both top-down and bottom-up approaches.

Praveen Kumar

Head & Director of Sales